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Abstract 
 Background: We aimed to describe and quantify postoperative complications in the older 
hip fracture population, develop and validate a hip fracture postoperative morbidity survey 
tool (HF–POMS).  
Methods: A prospective clinical observation study of patients (≥ 70 years) admitted for 
emergency hip fracture surgery, was conducted across three English National Health Service 
hospitals. Outcome data items were developed from the Postoperative Morbidity Survey 
(POMS), Cardiac-POMS, hip fracture postoperative literature and orthogeriatric clinical team 
input. Postoperative outcome data were collected on days 1, 3, 5, 8 and 15; 341 patients 
participated.  
Results: A 12-domain HF-POMS tool was developed with acceptable construct validity on 
all HF–POMS days. Patients with high perioperative risk scores as measured by the NHFS 
and ASA grade were more prone to develop HF–POMS defined morbidities. High morbidity 
rates occurred in the following domains; renal, ambulation assistance, pain and infectious. 
Presence of any morbidity on postoperative days 8 and 15 was associated with subsequent 
length of stay of 3.08 days (95% CI 0.90 – 5.26, p= 0.005) and 15.81 days (95% CI 13.35 – 
18.27, p = 0.001) respectively. Observed average length of stay was 16.9 days. HF–POMS is 
a reliable and valid tool for measuring early postoperative complications in hip fracture 
patients. Additional domains are necessary to account for all morbidity aspects in this patient 
population compared to the original POMS. 
Conclusion: Many patients remained in hospital for non-medical reasons. HF-POMS may be 
a useful tool to assist in discharge planning and randomised control trial outcome definitions.  
 
Key words – hip fracture, postoperative morbidity survey, outcomes, complications, 
mortality, length of hospital stay 
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Introduction 
Elderly patients undergoing emergency hip fracture surgery have a high risk of perioperative 
complications and death. In the UK, postoperative mortality ranges between 7-11% at one 
month, 16-28% at six months and 22-37% at one year 1 2. In-hospital postoperative 
morbidities are more frequent (17-50%) and often complex. A significant proportion of hip 
fracture survivors have decreased ability to perform activities of daily living; 50% do not 
regain their pre-fracture functional status and 10-20% of those admitted from home require 
long term institutional care 2. Accurate identification, quantification and care of short-term 
morbidity after hip fracture surgery is important since these conditions are strongly associated 
with mortality and length of hospital stay 3, impact long-term survival 4, and resource 
management.  
Current hip fracture care lacks a standardised categorisation of clearly defined early 
undesirable postoperative clinical outcome measures that can individually or collectively 
result in lower quality of life.  The postoperative morbidity survey (POMS, appendix 1) 5 was 
developed from a heterogeneous elective patient population producing a nine-domain tool, 
each domain with specific defined criteria, to provide consensus in measurement and 
reporting of outcome following surgery. Its primary purpose is to identify the presence of 
complications that delay hospital discharge. The tool was further validated in several studies 3 
6-8 demonstrating acceptable inter-rater reliability, accuracy in capturing criteria defined 
morbidities, and association with length of hospital stay (LOS). Other studies have shown 
POMS to be associated with both LOS and other pre-operative comorbidities 9-11.  
 However, to date the POMS has not been evaluated specifically in hip fracture patients. Its 
use and performance is likely to vary when applied to specific patient populations, reflected 
in the modification of the original POMS from a nine-domain item to the cardiac 
postoperative morbidity score (C-POMS, appendix1) 12 which is a 13-domain discharge 
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score. The distinctive morbidity aspects and disparities across surgical specialities necessitate 
the need for a speciality specific POMS 7 12. We hypothesise that patients undergoing fragility 
hip fracture surgery are most likely to express morbidity related to mobility, and pain aspects 
due to both mechanical injury and surgical trauma 13 14. After hip fracture from a fall, there 
may be psychological implications, fear and anxiety about walking again. The aims of this 
study were to describe and quantify postoperative complications in the older hip fracture 
population, and develop and validate a hip fracture postoperative morbidity survey tool (HF–
POMS). 
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Methods 
A prospective clinical observational cohort study was conducted across three English 
National Health Service (NHS) Hospitals. Study recruitment commenced in April 2015 and 
ended on 31st July 2016. Ethical approval was received from the East Midlands – 
Northampton NRES Committee – study ethics number 15/EM/0054 and local NHS research 
and development permission was granted before study commencement. The study complied 
with Good Clinical Practice standards set forth in the Declaration of Helsinki of 1975 15. 
Patients were recruited from orthopaedic and trauma wards following surgery. Inclusion 
criteria were: male or female; ≥ 70 years old; emergency admission with primary fracture of 
the hip and able to gain written informed consent from the patient or personal consultee. 
Initial recruitment (n = 100) was solely patients able to consent for themselves. Following 
study amendment, the final 241 participants included both those unable to give their own 
consent and those who could provide consent. Exclusion criteria were: terminal illness, 
pathological fracture, in-hospital fractures, and patients enrolled in a medicinal product 
interventional trial. 
Study items of interest and criteria definitions were initially identified from both the original 
POMS 5 7 and C-POMS 12. A literature search, to identify any additional commonly observed 
complications after hip fracture surgery was performed. A draft list of potential additional 
and amended items was circulated to six orthogeriatricians for their views, comments and 
addition of items they considered important from clinical experience.    
Three steps were taken to identify redundant items, a) a pairwise correlation matrix of all 
items on the data collection form was performed, b) item prevalence within the study 
population and c) all new identified items were sent to a team of orthogeriatricians for 
comments on item clinical severity, importance and the likelihood of currently being captured 
by the POMS [7].  
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Items with a correlation of > 0.8 were excluded. Using feedback and comments from the 
specialty team, items for inclusion had to meet three of the following criteria: 
(i) The identified morbidity item prevalence must be ≥ 5% 
(ii) Whether the morbidity item identified is likely to be captured by the original POMS 
or otherwise. The likelihood was measured using a 5-point Likert scale with threshold 
for inclusion set as median < 3 (i.e. unlikely to be captured) 
(iii) The likelihood that the patient remains in acute care due to this morbidity item. 
Scored on a 5-point Likert scale. Threshold for inclusion was set as median ≥3.5 (i.e. 
likely to be associated with remaining in acute care) 
(iv) Severity of the morbidity item in explaining post-operative morbidity requiring 
clinical management. Scored on a 5-point Likert scale. Threshold for inclusion set as 
median ≥3.5 (i.e. likely to require clinical management) 
Each item was further reviewed by the research team and final items for inclusion agreed by 
discussion.  
Participants were followed up on days 1, 3, 5, 8 and 15 post-surgery during their hospital stay 
at the primary admission hospital, documenting presence or absence of morbidities according 
to the defined criteria. Data were gathered from various sources (patient notes, treatment 
charts, biochemistry results, patient questioning and patient observation). Perioperative risk 
was estimated using the Nottingham Hip Fracture Score (NHFS) 16 17 and the American 
Society of Anaesthesiology physical assessment (ASA) 18 19. Mobility was measured using a 
modified Cumulated Ambulation Score (CAS) 20. Length of stay was defined as the 
difference in days between the date of discharge from the acute orthopaedic ward and the 
date of admission in the index episode. Data were coded and collated into a Microsoft Access 
database. 
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 Statistical analysis 
Descriptive statistics were used for demographic data and summary results of the pre-
operative comorbidities. We categorized duration of hospital stay variable by study site and 
age. Multivariate logistic regression was used to determine the independent association 
between LOS and individual HF-POMS domains. Internal consistency was measured using 
Cronbach alpha for validity and reliability 21. Cross-data collection validation (inter-rater 
reliability) was measured using Cohen’s Kappa 22.  Chi-squared test was used to compare risk 
of morbidity in general surgery patients and hip fracture patients. Results were considered 
significant with p values <0.05 and all p values were two sided. All calculations were 
performed using R statistical package 23. 
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Results 
A total of 647 patients were screened and 347 recruited into the study. Six patients were 
withdrawn on review, not meeting the inclusion criteria, leaving 341 patients for final 
analysis. The observed in-hospital mortality rate was 2.4%. Seventy-four (21.7%) of the 
participants were male and 267 (78.3%) female. Mean age was, 83.5 [range 70 - 108]. Two 
hundred and four (59%) had an ASA score of III, IV and V combined. The NHFS median 
score (IQR [range]) was 4.0 (4.0, 5.0 [3.0-9.0]). Mean (SD) LOS was 16.9 (11.2) days [range 
4-87]. We observed a variation in mean LOS across study sites (UHL 12.9 days, NUH 17.4 
days, and STH 26.5 days) and across age groups (70-79 years 14.1 days, 80-89 years 16.5 
days and ≥90 years 21.7days). Arthroplasty was performed in 175 patients (51.3%) and hip 
screws in 164 (48.7%). Three hundred and three (89%) of the patients were admitted from 
their own home with 38 (11%) admitted from residential institutions. One hundred and 
eighty-eight (55.1%) were discharged to their own homes, 86 (25%) to rehabilitation / 
community hospitals while 59 (17.3%) went to long-term institutions. All participants (n = 
341) were inpatients on days 1 and 3, reducing thereafter (day 5, n = 329; day 8, n = 303; day 
15 n = 167). 
Table1 Descriptive characteristics of patients included in the study.  
HF-POMS development 
In addition to the original POMS items, 19 new morbidity items were identified. Six items 
had a prevalence of <5%; all new items were observed to have a low likelihood to be 
captured by the original POMS. Thirteen items where considered to have a high likelihood of 
influencing patient stay in hospital and eight of all new items were considered to be highly 
important in describing and quantifying post-operative complications requiring clinical 
management after hip fracture surgery. Assisted ambulation (mobility) and psychological 
domains new items were therefore included, and pain domain criteria definition modified. 
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Each of the original POMS domains had a prevalence ≥ 5% except the wound and pain (as 
defined in POMS) domains with observed prevalence of 1.5% and 1% respectively. 
Parenteral opioids use is the key criteria definition of the pain domain in POMS, however 
after hip fracture surgery intravenous opioid use is generally avoided accounting for the low 
observed rates of this domain in this study. Similarly, wound complication rates are known to 
be low following hip fracture surgery. 
Thirteen items met the inclusion criteria requirements and were therefore included in the final 
proposed HF-POMS, with twelve morbidity domains. Within the new pain domain criteria 
definition, oral opioids specifically relate to oral morphine and oxycodone as required (PRN) 
for pain related to surgery, excluding codeine phosphate and dihydrocodeine.  
Table 2 HF–POMS domains and definition criteria 
Reliability and Construct validity 
Internal consistency was measured using Cronbach’s alpha. Overall raw alpha value was 0.54 
(95% CI 0.47 - 0.60) and for individual postoperative days alpha values were low-moderate; 
day 1 = 0.38, day 3 = 0.42, day 5 = 0.47, day 8 = 0.47 and day 15 = 0.63. Inter-observer 
variation measurement showed substantial agreement (kappa 0.68, p = 0.001). 
Patients with higher perioperative risk scores (NHFS > 4 and those with ASA grades III-V) 
developed more HF–POMS defined morbidities (appendix 2) and had increased subsequent 
LOS. Any increase in NHFS and ASA predicted an increase in LOS by 2.0 days (95% CI 0.5 
– 3.5, p = 0.008) and 2.5 days (95% CI 0.6 – 4.5, p = 0.012) respectively. 
Prevalence of HF-POMS 
Overall HF-POMS observed morbidities decreased by postoperative day (Figure 1, Table 3). 
The five domains with highest prevalence were assisted ambulation, renal, pain and 
infectious. Ambulation assistance ranged from 98% – 58% present on days 1, 3 and 5, renal 
81% – 46%, pain 62% – 31% and infectious 58% – 9% during the same period.  Moderately 
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high morbidity levels were observed in the gastrointestinal, cardiovascular and neurological 
domains and low levels in the psychological, wound, endocrinology, haematology and 
pulmonary domains. The proportion of patients remaining in hospital without HF-POMS 
morbidity increased with time: 19% on day 5, 38% day 8, 58% day 15. By day 15, 51% of 
patients were discharged from hospital. 
Using data from the Middlesex postoperative morbidity survey study 24, we compared the 
prevalence of common morbidity domains in our study population (after domain criteria 
definition modification for HF-POMS) to general surgery inpatients on postoperative days 5, 
8 and 15 (Figure 2). The pattern of high prevalence morbidity varied significantly (day 5 
p<0.013, day 8 p<0.001 and day 15 p<0.001; Chi-squared) between general surgery 
(gastrointestinal, infectious, wound, and pulmonary) and hip fracture patients (mobility, 
renal, pain, and infectious). Variation in morbidity prevalence between the two cohorts were 
statistically significant (p<0.038) in almost all morbidity domains across the three 
postoperative days.  
Table 3 Summary of HF–POMS morbidity rates 
Figure 1 HF-POMS daily morbidity 
Figure 2 Morbidity Prevalence: Comparison of common HF-POMS (above) and POMS 
(below) domain prevalence between hip fracture patients (n=341) and general surgery 
patients (n= 439), from the Middlesex postoperative survey study 24 
Predictive ability of HF-POMS 
Presence of any HF-POMS morbidity compared to absence of morbidity on day 8 and 15 was 
associated with an increase in subsequent LOS by 3.1 days (95% CI 0.9 – 5.3, p= 0.005) and 
15.8 days (95% CI 13.4 – 18.3, p = 0.001) respectively. The renal domain was observed to be 
an independent predictor of LOS across all HF–POMS days and assisted ambulation in all 
other days except day 1. 
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Figure 3 Adjusted Length of stay by morbidity domain per HF-POMS day. 
 
Other reasons identified for staying in hospitals 
Social reasons (appendix 3) are additional to non-medical reasons for why some of the 
patients remained in hospital. 
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Discussion 
Our study results support the development of a hip fracture specific POMS. The pattern of 
morbidity following hip fracture is clinically different to the original POMS: HF-POMS 
demonstrates the expected relationships with time, known predictors of risk and presence of 
HF-POMS is predictive of prolonged length of stay. In common with previous work, and 
patient and clinical experience, a significant number of patients remain in acute hospital care 
following fracture without overt medical reason.  
The 2.4% in-hospital mortality rate is in line with previous studies 25 and the average LOS of 
16.9 days similar to the national average 1. The overall studied population was biased slightly 
towards a fitter group, due to the initial recruitment of participants with capacity only. There 
are differences in local practice around acute hospital discharge between the three units, 
reflected in the differing lengths of stay. 
Higher risk patients have greater morbidity 19 and in turn, morbidity is predictive of 
subsequent length of stay 26. The HF-POMS has face validity as it has been developed solely 
from emergency hip fracture patients and morbidity domains identified are commonly known 
hip fracture complications 27 known to associate with LOS 28-30.  
Studies that validated the original POMS 3 6-8 in various surgeries have shown that individual 
POMS domains can predict LOS. The domain associated with greatest increase in length of 
stay (endocrine) was relatively infrequent (6%) and so is probably less clinically relevant. In 
contrast, impaired mobility has the greatest overall impact – with a large proportion of 
patients, and a moderate increase in LOS.  
Grocott and colleagues 7 found that orthopaedic patients were less likely to have POMS 
defined morbidity. For similar domains in POMS, our study participants have exhibited a 
high presence of pain (14% – 62%), renal (14% – 81%) and infectious (7% – 58%) 
morbidity. There are several reasons to be considered for these differences. First, all patients 
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considered in our study are emergency admissions requiring urgent surgery compared to the 
previous study 7 where major elective surgery patients were enrolled. Secondly, age 
difference; we recruited patients aged ≥70 years compared to ≥18 years in the original 
studies. Older age has been associated with high risk of perioperative morbidity, mortality 
and increased LOS 2 10. This has also been observed by Howes and colleagues 3 in their study 
validating POMS in emergency laparotomy patients.  
POMS has already been developed for use in a specific patient population 12 and our work 
builds on this approach. Some morbidity domains are strongly influenced by type of surgery 
– hence the differential rate of gastrointestinal morbidity between general surgical and hip 
fracture patients. In comparison to the POMS with nine morbidity categories, the HF-POMS 
has twelve morbidity domain categories with psychological, assistant mobilisation and 
endocrinology domains added. We made a conscious decision to change the pain criteria. Hip 
fracture is painful but intravenous opioids are not routinely used in the hip fracture 
population. 
An assisted ambulation domain was developed to account for new or escalated postoperative 
requirement for mobility assistance with two people and walking aid(s). Endocrine-metabolic 
complications in hip fracture population have previously been reported in 30% of patients 27 
although lower rates were observed in this study.  
A new psychological domain has been included. The prevalence and ramifications of fear of 
falling causing anxiety after hip fracture surgery are well-documented 31. Two separate 
studies reported fear of falling ranging from 21%-85% 32 and 60% at four weeks and 47% at 
12 weeks 33 after hip fracture. These factors do not influence LOS during the early post-
operative period, however if still present by day 15 are associated with longer LOS. Hospital 
discharge is potentially delayed in those with anxiety of falling as they restrict their activities 
in an effort to reduce the risk.  
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A few study limitations were observed in this study. Our age inclusion criterion was 70 years 
and above which could limit generalisation of the results to patient below this age; this is a 
small proportion of patients with hip fracture. Seventy-one percent of participants from one 
of the study sites (UHL) had their NHFS missing as the data is not routinely collected. Low-
moderate internal consistency was observed among the morbidity domains suggesting that 
the tool might not be suitable to be used as a summary score reflecting the views of Grocott 7. 
The increased serum creatinine levels as defined by the HF-POMS were observed in a very 
low number of participants (only 1%). This could have been due to the limited access to 
biochemistry results available for the study team. Furthermore, such blood tests are not a 
daily routine. Additionally, although minor degrees of acute kidney injury are a risk factor for 
poorer outcome, it is asymptomatic and seem unlikely to be a cause for staying in acute care 
per se 34. 
Data for HF–POMS were collected from three NHS sites and inter-rater reliability was good 
reflecting its potential for nationwide application.  All research sites were acute care trusts 
and morbidity was measured during hospital stay. As a standard discharge guide framework, 
HF-POMS could be used to categorise patients at different levels within the discharge 
pathway improving early discharge particularly with the current bed pressures in the NHS. 
Moreover, this might determine discharge destination, whether the patient will be transferred 
from acute care to a community hospital, intermediate care or residential home for further 
rehabilitation or they will be discharged back to their own home. 
The HF–POMS does not address non-medical aspects affecting prolonged hospital stay. 
Several non-morbidity factors have been identified keeping the patients in hospital 7 12. In this 
study we observed 8% remained in hospital for social reasons only on day 15.  
In the light of the validation provided by this study we believe that HF-POMS has potential 
value for local quality improvement and audit, commissioning and research. At an immediate 
15 
 
 
practical level, it may assist members of the hip fracture care pathway in discussing and 
making discharge plans. We have described the variation in morbidity factors at different 
stages post-surgery. High morbidity scores at any post-operative point are associated with a 
longer length of stay. 
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Tables and Figures legends 
Table 1: Baseline characteristics of patients included in the study (n=341) 
Table 2: Hip Fracture Postoperative Morbidity Score (HF-POMS): domains and criteria 
definition 
Table 3: Total Morbidity Present, n (%) 
Figure 1: HF-POMS daily morbidity 
Figure 2: Comparison of common HF-POMS (above) and POMS (Middlesex) (below) domains 
prevalence between hip fracture patients (n=341) and general surgery patients (n= 439), 
from the Middlesex postoperative survey study 24 
Figure 3: Adjusted increase in LOS by morbidity domain per HF-POMS day 
